Caries vaccine

Last updated

A caries vaccine is a vaccine to prevent and protect against tooth decay. [1] Streptococcus mutans (S. mutans) has been identified as the major etiological agent of human dental caries. The development of a vaccine for tooth decay has been under investigation since the 1970s. In 1972, a caries vaccine was said to be in animal testing in England, and that it would have begun human testing soon. [2] However, intrinsic difficulties in developing it, coupled with lack of strong economic interests, are the reasons why still no such vaccine is commercially available today.[ citation needed ] Several types of vaccines are being developed at research centres, with some kind of caries vaccines being considered to diminish or prevent dental caries' impact on young people. [3]

Contents

Attempts using antibodies

Early attempts followed a traditional approach to vaccination where normal S. mutans was introduced to promote a reaction from the immune system, stimulating antibody production. [4]

Planet Biotechnology developed a monoclonal antibody against S. mutans, branded CaroRx, produced with transgenic tobacco plants. It is a therapeutic vaccine, applied once every several months. Phase II clinical trials were discontinued in 2016.

The International Association for Dental Research and American Association for Dental Research announced a study performed by the Chinese Academy of Sciences which looked at using an inhaled vaccine that uses a protein filament as a delivery vehicle. Trials performed in rats showed an increase in antibody response along with a decrease in the amount of Streptococcus mutans adhering to teeth, leading to significantly fewer cavities observed among the test population. [5]

Attempts using replacement therapy

On a different line of research, Jeffrey Hillman from the University of Florida [6] developed a genetically modified strain of Streptococcus mutans called BCS3-L1, that is incapable of producing lactic acid – the acid that dissolves tooth enamel – and aggressively replaces native flora. In laboratory tests, rats who were given BCS3-L1 were conferred with a lifetime of protection against S. mutans. [7] BCS3-L1 colonizes the mouth and produces a small amount of a lantibiotic, called MU1140, [7] which allows it to out-compete S. mutans. [8] Hillman suggested that treatment with BCS3-L1 in humans could also provide a lifetime of protection, or, at worst, require occasional re-applications. He stated that the treatment would be available in dentists' offices and "will probably cost less than $100." [9] The product was being developed by Oragenics, but was shelved in 2014, citing regulatory concerns and patent issues. [10] In 2016, Oragenics received a 17-year patent for the product. [11] In 2023, the startup Lumina Probiotic began offering BCS3-L1 application in Próspera, Honduras.

On rare occasions the native S. mutans strain escapes into the blood, potentially causing dangerous heart infections. It is unclear how likely BCS3-L1 is to do the same. [12]

Another approach is being pursued by BASF, focused on replacing native lactobacillus flora with a variety dubbed L. anti-caries, which prevents S. mutans from binding to enamel. [13] However, it is not a long-term vaccination in that no attempt is being made to have a self-sustaining population of L. anti-caries. The intent is that the L. anti-caries population would be frequently replenished through use of a chewing gum containing the organism.

The University of Leeds has also begun researching a recently discovered peptide known as P11-4. When applied to a cavity and coming in contact with saliva, this peptide assembles itself in a fibrous matrix or scaffold, attracting calcium and thereby allowing the tooth to regenerate. [14] [15] The Swiss-based company Credentis has licensed the peptide and launched a product called Curodont Repair in 2013. [16] Recent studies show a positive clinical effect. [17]

DNA vaccines

DNA vaccine approaches for dental cavities have had a history of success in animal models. Dental cavity vaccines directed to key components of S. mutans colonization and enhanced by safe and effective adjuvants and optimal delivery vehicles, are likely to be forthcoming. Some believe that the rational target for developing an anti-caries vaccine is a protein antigen, which has adherent functional and important immunogenic regions. [18] [ clarification needed ]

Bacteriophage treatment

The use of Enterococcus faecalis bacteriophages as a form of treatment for caries has been considered, as they are capable of maintaining persistent stability in human saliva. [19]

Related Research Articles

<span class="mw-page-title-main">Xylitol</span> Synthetic sweetener

Xylitol is a chemical compound with the formula C
5
H
12
O
5
, or HO(CH2)(CHOH)3(CH2)OH; specifically, one particular stereoisomer with that structural formula. It is a colorless or white crystalline solid that is freely soluble in water. It can be classified as a polyalcohol and a sugar alcohol, specifically an alditol. The name derives from Ancient Greek: ξύλον, xyl[on] 'wood', with the suffix -itol used to denote sugar alcohols.

<span class="mw-page-title-main">Tooth enamel</span> Major tissue that makes up part of the tooth in humans and many animals

Tooth enamel is one of the four major tissues that make up the tooth in humans and many animals, including some species of fish. It makes up the normally visible part of the tooth, covering the crown. The other major tissues are dentin, cementum, and dental pulp. It is a very hard, white to off-white, highly mineralised substance that acts as a barrier to protect the tooth but can become susceptible to degradation, especially by acids from food and drink. In rare circumstances enamel fails to form, leaving the underlying dentin exposed on the surface.

<span class="mw-page-title-main">Tooth decay</span> Deformation of teeth due to acids produced by bacteria

Tooth decay, also known as cavities or caries, is the breakdown of teeth due to acids produced by bacteria. The cavities may be a number of different colors from yellow to black. Symptoms may include pain and difficulty with eating. Complications may include inflammation of the tissue around the tooth, tooth loss and infection or abscess formation.

Dental sealants are a dental treatment intended to prevent tooth decay. Teeth have recesses on their biting surfaces; the back teeth have fissures (grooves) and some front teeth have cingulum pits. It is these pits and fissures that are most vulnerable to tooth decay because food and bacteria stick in them and because they are hard-to-clean areas. Dental sealants are materials placed in these pits and fissures to fill them in, creating a smooth surface which is easy to clean. Dental sealants are mainly used in children who are at higher risk of tooth decay, and are usually placed as soon as the adult molar teeth come through.

<i>Streptococcus mutans</i> Species of bacterium

Streptococcus mutans is a facultatively anaerobic, gram-positive coccus commonly found in the human oral cavity and is a significant contributor to tooth decay. It is part of the "streptococci", an informal general name for all species in the genus Streptococcus. The microbe was first described by James Kilian Clarke in 1924.

Dental plaque is a biofilm of microorganisms that grows on surfaces within the mouth. It is a sticky colorless deposit at first, but when it forms tartar, it is often brown or pale yellow. It is commonly found between the teeth, on the front of teeth, behind teeth, on chewing surfaces, along the gumline (supragingival), or below the gumline cervical margins (subgingival). Dental plaque is also known as microbial plaque, oral biofilm, dental biofilm, dental plaque biofilm or bacterial plaque biofilm. Bacterial plaque is one of the major causes for dental decay and gum disease.

The dental pellicle, or acquired pellicle, is a protein film that forms on the surface enamel, dentin, artificial crowns, and bridges by selective binding of glycoproteins from saliva that prevents continuous deposition of salivary calcium phosphate. It forms in seconds after a tooth is cleaned, or after chewing. It protects the tooth from the acids produced by oral microorganisms after consuming carbohydrates.

<span class="mw-page-title-main">Early childhood caries</span> Dental disease of young children

Early childhood caries (ECC), formerly known as nursing bottle caries, baby bottle tooth decay, night bottle mouth and night bottle caries, is a disease that affects teeth in children aged between birth and 71 months. ECC is characterized by the presence of 1 or more decayed, missing, or filled tooth surfaces in any primary tooth. ECC has been shown to be a very common, transmissible bacterial infection, usually passed from the primary caregiver to the child.The main bacteria responsible for dental cavities are Streptococcus mutans (S.mutans) and Lactobacillus. There is also evidence that supports that those who are in lower socioeconomic populations are at greater risk of developing ECC.

<span class="mw-page-title-main">Dental caries (non-human)</span>

Dental caries, also known as tooth decay, is uncommon among companion animals. The bacteria Streptococcus mutans and Streptococcus sanguis cause dental caries by metabolising sugars. Prehistoric primates eating fruit suffer from cavities.

<span class="mw-page-title-main">Oral microbiology</span>

Oral microbiology is the study of the microorganisms (microbiota) of the oral cavity and their interactions between oral microorganisms or with the host. The environment present in the human mouth is suited to the growth of characteristic microorganisms found there. It provides a source of water and nutrients, as well as a moderate temperature. Resident microbes of the mouth adhere to the teeth and gums to resist mechanical flushing from the mouth to stomach where acid-sensitive microbes are destroyed by hydrochloric acid.

<span class="mw-page-title-main">Oral hygiene</span> Cleaning the mouth by brushing the teeth and cleaning in between the teeth

Oral hygiene is the practice of keeping one's oral cavity clean and free of disease and other problems by regular brushing of the teeth and adopting good hygiene habits. It is important that oral hygiene be carried out on a regular basis to enable prevention of dental disease and bad breath. The most common types of dental disease are tooth decay and gum diseases, including gingivitis, and periodontitis.

<span class="mw-page-title-main">Fluoride varnish</span> Highly concentrated form of fluoride

Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy. It is not a permanent varnish but due to its adherent nature it is able to stay in contact with the tooth surface for several hours. It may be applied to the enamel, dentine or cementum of the tooth and can be used to help prevent decay, remineralise the tooth surface and to treat dentine hypersensitivity. There are more than 30 fluoride-containing varnish products on the market today, and they have varying compositions and delivery systems. These compositional differences lead to widely variable pharmacokinetics, the effects of which remain largely untested clinically.

Ortek Therapeutics, Inc. is a private healthcare company based in Roslyn Heights, New York, which specializes in researching and commercializing oral care products. It was founded in 1998.

<span class="mw-page-title-main">Remineralisation of teeth</span>

Tooth remineralization is the natural repair process for non-cavitated tooth lesions, in which calcium, phosphate and sometimes fluoride ions are deposited into crystal voids in demineralised enamel. Remineralization can contribute towards restoring strength and function within tooth structure.

<span class="mw-page-title-main">Willoughby D. Miller</span>

Willoughby Dayton Miller (1853–1907) was an American dentist and the first oral microbiologist.

Oral ecology is the microbial ecology of the microorganisms found in mouths. Oral ecology, like all forms of ecology, involves the study of the living things found in oral cavities as well as their interactions with each other and with their environment. Oral ecology is frequently investigated from the perspective of oral disease prevention, often focusing on conditions such as dental caries, candidiasis ("thrush"), gingivitis, periodontal disease, and others. However, many of the interactions between the microbiota and oral environment protect from disease and support a healthy oral cavity. Interactions between microbes and their environment can result in the stabilization or destabilization of the oral microbiome, with destabilization believed to result in disease states. Destabilization of the microbiome can be influenced by several factors, including diet changes, drugs or immune system disorders.

Streptococcus sobrinus is a Gram-positive, catalase-negative, non-motile, and anaerobic member of the genus Streptococcus.

Biotene is an over-the-counter dental hygiene product currently marketed GSK plc. It comes in a number of forms, including toothpaste, mouthwash and gel.

<span class="mw-page-title-main">Tooth pathology</span> Medical condition

Tooth pathology is any condition of the teeth that can be congenital or acquired. Sometimes a congenital tooth disease is called a tooth abnormality. These are among the most common diseases in humans The prevention, diagnosis, treatment and rehabilitation of these diseases are the base to the dentistry profession, in which are dentists and dental hygienists, and its sub-specialties, such as oral medicine, oral and maxillofacial surgery, and endodontics. Tooth pathology is usually separated from other types of dental issues, including enamel hypoplasia and tooth wear.

<span class="mw-page-title-main">Oligopeptide P11-4</span> Chemical compound

Oligopeptide P11-4 is a synthetic, pH controlled self-assembling peptide used for biomimetic mineralization e.g. for enamel regeneration or as an oral care agent. P11-4 consists of the natural occurring amino acids Glutamine, Glutamic acid, Phenylalanine, Tryptophan and Arginine. The resulting higher molecular structure has a high affinity to tooth mineral. P11-4 has been developed and patented by The University of Leeds (UK). The Swiss company Credentis has licensed the peptide technology and markets it under the trade names including CUROLOX, REGENAMEL, and EMOFLUOR. They offer three products with this technology. As of June 2016 in Switzerland products are available with new Brand names from Dr. Wild & Co AG.

References

  1. "Panel on Caries Vaccine". National Institute of Dental and Craniofacial Research of the National Institute of Health. January 28, 2003. Archived from the original on 2011-09-29. Retrieved 14 April 2008.
  2. Bowen, W.H. (December 1972). "Dental caries". Archives of Disease in Childhood. 47 (256): 849–53. doi:10.1136/adc.47.256.849. PMC   1648396 . PMID   4567073.
  3. Richie, Chhabra; Karan, Rajpal (Jan 2016). "Caries vaccine: A boom for public health". Annals of Tropical Medicine & Public Health. 9 (1): 1–3. doi: 10.4103/1755-6783.168715 . S2CID   57200550.
  4. Martin A. Taubman; Daniel J. Smith (June 1974). "Effects of Local Immunization with Streptococcus mutans on Induction of Salivary Immunoglobulin A Antibody and Experimental Dental Caries in Rats". Infection and Immunity. 9 (6): 1079–1091. doi:10.1128/IAI.9.6.1079-1091.1974. PMC   414936 . PMID   4545425.
  5. Yang, Jingyi; Sun, Ying; Bao, Rong; Zhou, Dihan; Yang, Yi; Cao, Yuan; Yu, Jie; Zhao, Bali; Li, Yaoming; Yan, Huimin; Zhong, Maohua (2017). "Second-generation Flagellin-rPAc Fusion Protein, KFD2-rPAc, Shows High Protective Efficacy against Dental Caries with Low Potential Side Effects". Scientific Reports. 7 (1): 11191. Bibcode:2017NatSR...711191Y. doi:10.1038/s41598-017-10247-8. PMC   5593867 . PMID   28894188.
  6. "This Germ Could Save Your Life". Popular Science. Retrieved 2016-09-20.
  7. 1 2 "Replacement Therapy". ONI Biopharma. Retrieved 6 January 2009.
  8. Hillman, Jeffrey D. (August 2002). "Genetically modified Streptococcus mutans for the prevention of dental caries". Antonie van Leeuwenhoek. 82 (1–4): 361–366. doi:10.1023/A:1020695902160. PMID   12369203. S2CID   11066428.
  9. "Genetically modified bacteria may prevent caries". HealthMantra. January 2002. Retrieved 2006-12-18.
  10. "Wall Street Journal Interview with Oragenics' CEO, Dr. John Bonfiglio - Transcript" (PDF). April 2014. Archived from the original (PDF) on 2014-05-02. Retrieved 2014-05-01.
  11. "Oragenics Receives New Patent for Improved Replacement Therapy for Dental Caries" . Retrieved 8 January 2017.
  12. "Wash that mouth out with bacteria!". Science News. 18 March 2000.
  13. "Chewing gum with added bite". British Dental Journal. 201 (5): 255. 2006. doi: 10.1038/sj.bdj.4814014 .
  14. "Breakthrough could make dental drills obsolete". Healthier Talk. 9 April 2011. Archived from the original on 17 August 2016. Retrieved 27 May 2013.
  15. S Kyle; A Aggeli; M J McPherson; E Ingham (2008). "THE SELF-ASSEMBLING PEPTIDE, P11-4 AS A SCAFFOLD FOR USE IN REGENERATIVE MEDICINE" (PDF). European Cells & Materials. 16 (3): 70. ISSN   1473-2262. Archived from the original (PDF) on 2016-03-04. Retrieved 2013-05-27.
  16. "New Treatment Fixes Tooth Decay Without Drilling". Science Business. 24 August 2011.
  17. Schlee, M.; Rathe, F.; Huck, T.; Schad, T.; Koch, J.H.; Tjaden, A.; Bommer, C. (19 July 2014). "Klinischer Effekt biomimetischer Mineralisation bei Approximalkaries". Stomatologie. 111 (4–5): 175–181. doi: 10.1007/s00715-014-0335-4 .
  18. Guo, JH; Jia, R; Fan, MW; Bian, Z; Chen, Z; Peng, B (Mar 2004). "Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans". Journal of Dental Research. 83 (3): 266–270. doi:10.1177/154405910408300316. PMID   14981132. S2CID   46360161.
  19. G. Bachrach; M. Leizerovici-Zigmond; A. Zlotkin; R. Naor; D. Steinberg (December 2002). "Bacteriophage isolation from human saliva". Letters in Applied Microbiology. 36 (1): 50–53. doi: 10.1046/j.1472-765X.2003.01262.x . PMID   12485342. S2CID   34349845.